Cellectar Biosciences (CLRB)

Cellectar Biosciences Stock News & Insights

FLORHAM PARK, N.J., Sept. 22, 2022 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced it has been awarded $1.98 million in additional grant funding to expand its ongoing Phase 1 ...Read more

News Score - Last 7 Days

Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

Healthcare Stocks that are Trending in the News
XFORX4 Pharmaceuticals
LVTXLAVA Therapeutics
LLYEli Lilly & Co
Showing the stocks with the most bullish news sentiment over the past week

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis